US Stock MarketDetailed Quotes
TTOO T2 Biosystems
- 0.3500
- +0.0159+4.76%
Close Dec 20 16:00 ET
- 0.3500
- 0.00000.00%
Post 20:01 ET
7.37MMarket Cap-11.67P/E (TTM)
0.3587High0.3261Low541.76KVolume0.3299Open0.3341Pre Close186.91KTurnover6.82%Turnover RatioLossP/E (Static)21.04MShares8.379952wk High-0.63P/B2.78MFloat Cap0.310052wk Low--Dividend TTM7.95MShs Float122500.0000Historical High--Div YieldTTM9.76%Amplitude0.3100Historical Low0.3440Avg Price1Lot Size
About T2 Biosystems Company
T2 Biosystems, Inc. is a vitro diagnostics company, which engages in the development of detection of sepsis-causing pathogens. It offers T2Dx instrument, T2Bacteria, T2Candida, T2Biothreat panels, and T2MR technology. The company was founded by Michael J. Cima, Robert S. Langer Jr., Tyler Jacks, Lee Josephson, W. David Lee, and Ralph Weissleder on April 27, 2006 and is headquartered in Lexington, MA.
Company Profile
SymbolTTOO
Company NameT2 Biosystems
Listing DateAug 7, 2014
Issue Price11.00
Founded2006
CEOMr. John J. Sperzel, III
MarketNASDAQ
Employees113
Fiscal Year Ends12-31
Address101 Hartwell Avenue
CityLexington
ProvinceMassachusetts
CountryUnited States of America
Zip Code02421
Phone1-781-761-4646
Websitehttp://www.t2biosystems.com
Company Executives
- Name
- Position
- Salary
- John J. Sperzel, III
- Chairman of the Board, Chief Executive Officer and President
- 865.50K
- John M. Sprague
- Chief Financial Officer and Principal Accounting Officer
- 581.00K
- Brett A. Giffin
- Chief Commercial Officer
- --
- Michael Terrence Gibbs, Esq.
- Senior Vice President and General Counsel
- 622.60K
- Roger Smith, PhD
- Senior Vice President, Science Research and Development
- --
- David B. Elsbree
- Independent Director
- 60.00K
- Seymour E. Liebman
- Independent Director
- 40.00K
- Dr. Ninfa M. Saunders
- Independent Director
- 50.00K
- John W. Cumming
- Lead Independent Director
- 96.00K
- Robin Toft
- Independent Director
- 60.00K
- Laura Adams
- Independent Director
- 40.00K
Heat List
US
Overall
Symbol
Price
% Chg
No Data
